Home > Topic > Moderna

MODERNA

Moderna did not immediately respond to a request for comment. (AP)

Japan stops use of 1.63 million doses of Moderna vaccine over contamination

1 min read . Updated: 26 Aug 2021

All three drugmakers have raised their sales forecasts on Covid shots over the past two weeks. (AP)

Moderna, BioNTech extend record rally ahead of booster plans

2 min read . Updated: 10 Aug 2021

Moderna's COVID-19 vaccine was granted emergency use authorisation by India's drug regulator last month. (AFP)

India offered 7.5 million doses of Moderna vaccine through COVAX: Report

1 min read . Updated: 20 Jul 2021

Moderna's vaccine is the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik. (AFP)

Moderna covid vaccines to reach India this week

1 min read . Updated: 08 Jul 2021

Moderna's vaccine is the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik. (AFP)

Moderna covid vaccines to reach India this week

1 min read . Updated: 08 Jul 2021

FILE PHOTO: A vial of the Moderna COVID-19 vaccine is seen. (REUTERS)

Moderna Covid vaccine in India: Efficacy, doses, storage, possible 'side effects

4 min read . Updated: 01 Jul 2021

Shares of Moderna gained 5.9% at 10:24 a.m. in New York.

Moderna says its covid vaccine produces antibodies against delta variant

1 min read . Updated: 30 Jun 2021

A vial of the Moderna COVID-19 vaccine is seen at a clinic in Germany. (File photo)

Germany expects faster Moderna COVID-19 vaccine deliveries

1 min read . Updated: 27 Jun 2021

File Photo: Moderna said that approximately 18 million doses have been supplied to the US government to date (REUTERS)

Moderna raises annual Covid-19 vaccine production forecast to 600 mn doses

1 min read . Updated: 04 Jan 2021

FILE - In this Dec. 21, 2020 file photo, Michelle Chester, director of employee health services at Northwell Health, prepares the Moderna COVID-19 vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in Valley Stream, N.Y. An ambitious goal of vaccinating 1 million New York City residents against COVID-19 in January was set Thursday by Mayor Bill de Blasio, who noted that meeting the target would require outside cooperation and the city dramatically increasing access. (Eduardo Munoz/Pool via AP, File) (AP)

Covid vaccine: US may cut some Moderna doses in half to speed rollout

1 min read . Updated: 04 Jan 2021

The summit is likely to focus on distribution, with Trump planning to sign an order directing his Department of Health and Human Services to prioritize getting them to people in the U.S. before helping other countries. (AP)

Moderna, Pfizer won’t attend White House summit on vaccines

1 min read . Updated: 08 Dec 2020

Moderna jumped as much as 17% in Tuesday’s premarket trading (AFP)

Moderna mania draws comparisons to Bitcoin while shorts bleed

1 min read . Updated: 01 Dec 2020

This picture taken on November 18, 2020 shows a syringe and a bottle reading

Moderna soars to record ahead of final covid vaccine analysis

1 min read . Updated: 26 Nov 2020

Moderna chief sells more shares ahead of key vaccine filing

1 min read . Updated: 24 Nov 2020

Moderna has said it will be able to deliver 20 million doses of vaccine by the end of this year, enough to inoculate 10 million people. The U.S. will get the first batch. (AFP)

Moderna partner ramping up ingredient production for covid vaccine

1 min read . Updated: 19 Nov 2020

FILE - Sen. Kamala Harris (AP)

Will get COVID-19 under control by listening to experts, says Kamala

1 min read . Updated: 16 Nov 2020

Moderna expects to have enough safety data required for US authorization in the next week or so. reuters (MINT_PRINT)

'We can stop Covid-19': Moderna vaccine success gives world more hope

5 min read . Updated: 16 Nov 2020

FILE PHOTO: On the very day that Pfizer announced its vaccine was 90% effective against the coronavirus, its chief executive Albert Bourla sold shares worth $5.6 million (AP)

Covid-19: As lab execs sell shares worth millions, questions arise

3 min read . Updated: 16 Nov 2020

Moderna said Phase 3 study of its covid vaccine met statistical criteria with a vaccine efficacy of 94.5%

Moderna covid-19 vaccine found 94.5% effective at preventing coronavirus

3 min read . Updated: 16 Nov 2020

Moderna’s version is due to report results imminently (REUTERS)

Markets are already pricing a successful Moderna vaccine shot

1 min read . Updated: 13 Nov 2020

×

Get alerts on WhatsApp

Set Preferences My Reads Feedback Redeem a Gift Card Logout